These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 15842521
21. Statin use in Type 2 diabetes mellitus is associated with a delay in starting insulin. Yee A, Majumdar SR, Simpson SH, McAlister FA, Tsuyuki RT, Johnson JA. Diabet Med; 2004 Sep; 21(9):962-7. PubMed ID: 15317599 [Abstract] [Full Text] [Related]
22. Randomized controlled trial of Tinospora crispa for additional therapy in patients with type 2 diabetes mellitus. Sangsuwan C, Udompanthurak S, Vannasaeng S, Thamlikitkul V. J Med Assoc Thai; 2004 May; 87(5):543-6. PubMed ID: 15222526 [Abstract] [Full Text] [Related]
23. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes. Westphal SA, Palumbo PJ. Arch Intern Med; 2004 May; 163(15):1783-5; discussion 1785. PubMed ID: 12912711 [No Abstract] [Full Text] [Related]
24. Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial. Out M, Miedema I, Jager-Wittenaar H, van der Schans C, Krijnen W, Lehert P, Stehouwer C, Kooy A. Diabetes Obes Metab; 2018 Jan; 20(1):219-223. PubMed ID: 28681986 [Abstract] [Full Text] [Related]
25. A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects. Khedkar A, Iyer H, Anand A, Verma M, Krishnamurthy S, Savale S, Atignal A. Diabetes Obes Metab; 2010 Aug; 12(8):659-64. PubMed ID: 20590742 [Abstract] [Full Text] [Related]
26. Composition of insulin-induced body weight gain in diabetic patients: a bio-impedance study. Rigalleau V, Delafaye C, Baillet L, Vergnot V, Brunou P, Gatta B, Gin H. Diabetes Metab; 1999 Sep; 25(4):321-8. PubMed ID: 10566121 [Abstract] [Full Text] [Related]
27. [Early control of diabetic sequelae. Combined insulin treatment also in type 2]. MMW Fortschr Med; 2000 Jun 22; 142(25):57. PubMed ID: 10920674 [No Abstract] [Full Text] [Related]
28. The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P. J Altern Complement Med; 2007 Jun 22; 13(1):97-102. PubMed ID: 17309383 [Abstract] [Full Text] [Related]
29. Continuation of metformin after introduction of insulin in type 2 diabetes. Kooy A. BMJ; 2009 Nov 09; 339():b4227. PubMed ID: 19900992 [No Abstract] [Full Text] [Related]
30. Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial. de Jager J, Kooy A, Schalkwijk C, van der Kolk J, Lehert P, Bets D, Wulffelé MG, Donker AJ, Stehouwer CD. J Intern Med; 2014 Jan 09; 275(1):59-70. PubMed ID: 23981104 [Abstract] [Full Text] [Related]
31. Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial. Petrie JR, Chaturvedi N, Ford I, Hramiak I, Hughes AD, Jenkins AJ, E Klein B, Klein R, Ooi TC, Rossing P, Sattar N, Stehouwer CD, Colhoun HM, REMOVAL Trial Team. Diabetes Obes Metab; 2017 Apr 09; 19(4):509-516. PubMed ID: 27935183 [Abstract] [Full Text] [Related]
32. Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry. Gitt AK, Bramlage P, Binz C, Krekler M, Plate T, Deeg E, Tschöpe D, DiaRegis Study Group. Eur J Prev Cardiol; 2012 Aug 09; 19(4):765-72. PubMed ID: 21628353 [Abstract] [Full Text] [Related]
33. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D. Diabetes Care; 2003 Jan 09; 26(1):138-43. PubMed ID: 12502670 [Abstract] [Full Text] [Related]
34. [Therapeutic strategies in type 2 diabetes]. Waeber G, Vollenweider P, Ruiz J. Praxis (Bern 1994); 2001 Dec 20; 90(51-52):2245-54. PubMed ID: 11820166 [Abstract] [Full Text] [Related]
35. Diabetes control without weight gain. Health News; 1999 Apr 15; 5(5):6. PubMed ID: 10214130 [No Abstract] [Full Text] [Related]
36. A Naturalistic Randomized Placebo-Controlled Trial of Extended-Release Metformin to Prevent Weight Gain Associated With Olanzapine in a US Community-Dwelling Population. Rado J, von Ammon Cavanaugh S. J Clin Psychopharmacol; 2016 Apr 15; 36(2):163-8. PubMed ID: 26872112 [Abstract] [Full Text] [Related]
37. Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes. Swinnen SG, Dain MP, Mauricio D, DeVries JH, Hoekstra JB, Holleman F. Diabetes Obes Metab; 2010 Oct 15; 12(10):923-5. PubMed ID: 20920046 [Abstract] [Full Text] [Related]
38. [Insulin and weight gain: myth or reality?]. Larger E, Rufat P, Dubois-Laforgue D, Ledoux S. Diabetes Metab; 2001 Nov 15; 27(5 Pt 3):S23-7. PubMed ID: 11910976 [Abstract] [Full Text] [Related]
39. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Timmers S, de Ligt M, Phielix E, van de Weijer T, Hansen J, Moonen-Kornips E, Schaart G, Kunz I, Hesselink MK, Schrauwen-Hinderling VB, Schrauwen P. Diabetes Care; 2016 Dec 15; 39(12):2211-2217. PubMed ID: 27852684 [Abstract] [Full Text] [Related]
40. Metformin use in patients with diabetes mellitus and heart failure: friend or foe? Giamouzis G, Triposkiadis F, Butler J. J Card Fail; 2010 Mar 15; 16(3):207-10. PubMed ID: 20206894 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]